| Literature DB >> 35634275 |
Richard T Kangethe1, Eva M Winger1, Tirumala Bharani K Settypalli1, Sneha Datta1, Viskam Wijewardana1, Charles E Lamien1, Hermann Unger1, Theresa H T Coetzer2, Giovanni Cattoli1, Adama Diallo1,3.
Abstract
The protozoan parasite Trypanosoma evansi is responsible for causing surra in a variety of mammalian hosts and is spread by many vectors over a wide geographical area making it an ideal target for irradiation as a tool to study the initial events that occur during infection. Parasites irradiated at the representative doses 100Gy, 140Gy, and 200Gy were used to inoculate BALB/c mice revealing that parasites irradiated at 200Gy were unable to establish disease in all mice. Cytokine analysis of mice inoculated with 200Gy of irradiated parasites showed significantly lower levels of interleukins when compared to mice inoculated with non-irradiated and 100Gy irradiated parasites. Irradiation also differentially affected the abundance of gene transcripts in a dose-dependent trend measured at 6- and 20-hours post-irradiation with 234, 325, and 484 gene transcripts affected 6 hours post-irradiation for 100Gy-, 140Gy- and 200Gy-irradiated parasites, respectively. At 20 hours post-irradiation, 422, 381, and 457 gene transcripts were affected by irradiation at 100Gy, 140Gy, and 200Gy, respectively. A gene ontology (GO) term analysis was carried out for the three representative doses at 6 hours and 20 hours post-irradiation revealing different processes occurring at 20 hours when compared to 6 hours for 100Gy irradiation. The top ten most significant processes had a negative Z score. These processes fall in significance at 140Gy and even further at 200Gy, revealing that they were least likely to occur at 200Gy, and thus may have been responsible for infection in mice by 100Gy and 140Gy irradiated parasites. When looking at 100Gy irradiated parasites 20 hours post-irradiation processes with a positive Z score, we identified genes that were involved in multiple processes and compared their fold change values at 6 hours and 20 hours. We present these genes as possibly necessary for repair from irradiation damage at 6 hours and suggestive of being involved in the establishment of disease in mice at 20 hours post-irradiation. A potential strategy using this information to develop a whole parasite vaccine is also postulated.Entities:
Keywords: TryMS array; Trypanosoma evansi; gamma irradiation; surra ; vaccine
Mesh:
Year: 2022 PMID: 35634275 PMCID: PMC9136415 DOI: 10.3389/fimmu.2022.852091
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 8.786
Figure 1In-vitro growth analysis of irradiated parasites. Parasites irradiated at different doses were observed over a 7-day period post-irradiation and 200Gy was identified as the maximum dose applicable. Percentage survival was calculated from the number of wells containing parasites that survived in a 24 well plate. A parallel plate was used to measure replication of parasites labelled with CFSE, which halves in concentration with each doubling of parasites. Eight female BALB/c mice per group were each inoculated with 1 x 104 parasites irradiated with doses ranging from 600Gy to 100Gy and a control group received 1 x 104 non-irradiated parasites. Surviving mice were further challenged with 1 x 103 of either homologous T. evansi RoTat 1.2 or heterologous Can 86K strains.
Figure 2In-vivo characteristics of irradiated parasites at different doses. (A) Parasite counts in mice that developed an infection after inoculation with T. evansi RoTaT1.2 irradiated parasites on days 0 and 14 (↑) are plotted. Mice in groups inoculated with either 0Gy or 100Gy irradiated parasites all developed parasitemia although with a delayed prepatent period at day 4 for mice inoculated with 100Gy irradiated parasites. Only three mice in the group inoculated with 140Gy irradiated parasites were infected with parasites first appearing at day 9. (B) Parasite counts in mice that developed an infection after heterologous challenge with T. evansi Can 86K on day 28 (↑). (C) Kaplan Meier survival analysis shows a 15-day gap between mice inoculated with 0Gy and 100Gy irradiated parasites and the remaining 5 mice in the group inoculated with 140Gy irradiated parasites succumbing faster to heterologous challenge on day 28 compared to the remaining groups.
Figure 3Cytokine dynamics in mice immunized using irradiated parasites. Ten different cytokines were measured through the course of inoculation and challenge. Mice inoculated with 200Gy irradiated parasites had significantly lower levels of IFNγ, IL10, IL12b, IL13, IL1b and IL4 when compared to 0Gy (*). IL12a and IL6 were significantly lower when comparing 200Gy to 100Gy irradiated parasite inoculation (*). Significantly lower IL10, IL12a and IL12b were also observed in mice inoculated with 140Gy irradiated parasites (*). Analyses were calculated using one-way ANOVA for each cytokine, *p < 0.01.
Figure 4Transcription analysis of irradiated parasites using the TrypMS array. (A) PCA mapping separated samples according to time post-irradiation. (B) Hierarchical clustering of deferential gene transcripts according to time and further sub clustered using the gene ID. Fold change (FC) cut-off points of > 2 and < 2 were used as the limits for upregulation and downregulation respectively and a gene-level P-value < 0.05.
Figure 5General differences in gene transcript changes according to dose and time post-irradiation. (A) Bar graph showing the ratio of gene transcript abundance upregulated to downregulated at different doses at 6 and 20 hours post-irradiation. (B) Volcano plot of fold-change (FC) vs false discovery rate (FDR) p value for 200Gy irradiated parasites at 20h. (C) Venn diagram describing the distribution of 622 differential gene transcripts at 20 hours after irradiation with 259 genes common across all three doses when compared to 1 hour after irradiation, 102, 38 and 103 unique to 100Gy, 140Gy and 200Gy irradiation respectively.
A comparison of gene transcripts across different doses and time.
| Comparison | Down | Up | Total |
|---|---|---|---|
| 200Gy (1h vs 6h) | 223 | 261 | 484 |
| 200Gy (1h vs 20h) | 179 | 278 | 457 |
| 100Gy (1h vs 20h) | 141 | 281 | 422 |
| 140Gy (1h vs 20h) | 122 | 259 | 381 |
| 1h vs 20h (all doses) | 110 | 234 | 344 |
| 140Gy (1h vs 6h) | 141 | 184 | 325 |
| 1h vs 6h (all doses) | 109 | 138 | 247 |
| 100Gy (1h vs 6h) | 100 | 134 | 234 |
| 200Gy vs 250Gy | 125 | 71 | 196 |
| 0Gy vs 200Gy | 28 | 134 | 162 |
| 140Gy vs 250Gy | 84 | 57 | 141 |
| 100Gy vs 250Gy | 85 | 46 | 131 |
| 140Gy (6h vs 20h) | 3 | 128 | 131 |
| 0Gy vs140Gy | 22 | 96 | 118 |
| 6h vs 20h | 2 | 114 | 116 |
| 100Gy (6h vs 20h) | 4 | 108 | 112 |
| 200Gy (6h vs 20h) | 6 | 97 | 103 |
| 0Gy vs100Gy | 10 | 85 | 95 |
| 100Gy vs 200Gy | 0 | 47 | 47 |
| 6h (100Gy vs 200Gy) | 0 | 46 | 46 |
| 140Gy vs 200Gy | 0 | 33 | 33 |
| 0Gy vs 250Gy | 6 | 22 | 28 |
| 1h (0 vs 250Gy) | 6 | 22 | 28 |
| 1h (0 vs 200Gy) | 8 | 15 | 23 |
| 20h (100Gy vs 200Gy) | 0 | 18 | 18 |
| 1h (100Gy vs 250Gy) | 2 | 11 | 13 |
| 6h (140Gy vs 200Gy) | 0 | 8 | 8 |
| 1h (140Gy vs 250Gy | 1 | 6 | 7 |
| 1h (0 vs140Gy) | 2 | 4 | 6 |
| 1h (0 vs 100Gy) | 2 | 3 | 5 |
| 1h (100Gy vs 200Gy) | 2 | 2 | 4 |
| 100Gy vs 140Gy | 0 | 4 | 4 |
| 20h (100Gy vs140Gy) | 0 | 3 | 3 |
| 1h (140Gy vs 200Gy) | 1 | 1 | 2 |
| 1h (100Gy vs 140Gy) | 1 | 0 | 1 |
| 20h (140Gy vs 200Gy) | 0 | 1 | 1 |
| 6h (100Gy vs 140Gy) | 0 | 1 | 1 |
| 1h (200Gy vs 250Gy) | 0 | 0 | 0 |
| Interaction (1h and 6h vs 100Gy and 200Gy) | 47 | 5 | 52 |
| Interaction (1h and 20h vs 100Gy and 200Gy | 22 | 6 | 28 |
| Interaction (6h and 20h vs 100Gy and 200Gy) | 8 | 10 | 18 |
| Interaction (1h and 6h vs 140Gy and 200Gy) | 14 | 1 | 15 |
| Interaction (1h and 20h vs 100Gy and 140Gy) | 7 | 4 | 11 |
| Interaction (1h and 6h vs 100Gy and 140Gy) | 9 | 1 | 10 |
| Interaction (6h and 20h vs 140Gy and 200Gy) | 2 | 4 | 6 |
| Interaction (6 and 20 vs 100Gy and 140Gy) | 2 | 2 | 4 |
| Interaction (1 and 20 vs 140Gy and 200Gy) | 3 | 0 | 3 |
Figure 6Confirmatory qPCR. Twenty-two genes that were either downregulated (17) or upregulated (5) in all three doses at 20h post-irradiation were amplified using the same RNA samples that had previously been processed using the TrypMS array.
Figure 7GO enrichment terms with calculated Z scores plotted against FDR p value at 6h and 20h hours post-irradiation. The number of terms increases exponentially at 100Gy irradiation after 6h and 20h when compared to 140Gy and 200Gy irradiation with negative log FDR p significance values 10 log higher at 100Gy 20h than 100Gy 6h. Adjusted p values are important as they designate if a process is more likely to occur.
Comparison of Go Term FDR p values across doses at 6h (top half) and 20h (bottom half) post-irradiation.
| GO TERM | Description | 100Gy Adj | 140 Adj | 200Gy Adj |
|---|---|---|---|---|
| GO:0006333 | chromatin assembly or disassembly | 1.5E-11 | 2.1E-06 | 1.6E-02 |
| GO:0006334 | nucleosome assembly | 1.5E-11 | 8.4E-06 | 4.8E-02 |
| GO:0031497 | chromatin assembly | 1.5E-11 | 2.1E-06 | 1.6E-02 |
| GO:0034728 | nucleosome organization | 2.8E-11 | 2.8E-06 | 2.2E-02 |
| GO:0065004 | protein-DNA complex assembly | 1.4E-10 | 5.9E-05 | 1.2E-01 |
| GO:0006323 | DNA packaging | 1.8E-10 | 9.8E-06 | 5.2E-03 |
| GO:0071824 | protein-DNA complex subunit organization | 3.7E-10 | 1.6E-05 | 6.7E-02 |
| GO:0000785 | chromatin | 1.2E-08 | 2.5E-05 | 2.0E-02 |
| GO:0035328 | transcriptionally silent chromatin | 2.0E-08 | 2.6E-03 | 1.4E-03 |
| GO:0031490 | chromatin DNA binding | 4.7E-08 | 8.4E-03 | 2.1E-03 |
| GO:0003735 | structural constituent of ribosome | 3.5E-25 | N/A | 1.2E-02 |
| GO:0006518 | peptide metabolic process | 1.9E-24 | 1.3E-05 | 2.8E-03 |
| GO:0022626 | cytosolic ribosome | 5.9E-24 | 1.6E-06 | 2.7E-02 |
| GO:0006412 | translation | 8.8E-24 | 4.1E-05 | 1.0E-02 |
| GO:0043043 | peptide biosynthetic process | 8.8E-24 | 4.1E-05 | 1.0E-02 |
| GO:0043603 | cellular amide metabolic process | 3.4E-23 | 3.1E-05 | 3.2E-03 |
| GO:0043604 | amide biosynthetic process | 5.0E-23 | 7.1E-05 | 7.5E-03 |
| GO:0005198 | structural molecule activity | 1.9E-21 | N/A | 4.6E-02 |
| GO:0022625 | cytosolic large ribosomal subunit | 9.4E-18 | 3.0E-05 | 4.0E-02 |
| GO:0005840 | ribosome | 8.5E-16 | 2.7E-03 | 2.7E-01 |
N/A, Not Available.
Figure 8Top 10 most significant GO terms for 100Gy at 6h and 20h post-irradiation. GO circle plots for the top 10 most significant GO enrichment terms with fold-changes of individual genes taken in account and calculated as Z score at 20h post-irradiation. The height of the inner bar chat designates the significance of the GO term plotted. Most processes at both periods post-irradiation were down regulated.
Figure 9Chord plots for the positive Z score GO enrichment terms and associated genes at 6h and 20h post 100Gy irradiation. All the processes at 6h and 20h post-irradiation were plotted with corresponding genes to identify individual genes involved in multiple processes and given a chord plot count i.e., the higher the count a gene has, the more processes it will be involved with.
Genes found in positive Z score GO terms for 100Gy at 6h and 20h post-irradiation.
| Gene ID | Description | Chord plot count | 6 vs 1 FC | 20 vs 1 FC | 6h vs 20h | Time FDR |
|---|---|---|---|---|---|---|
| Tb927.10.14130 | SRP19 protein, putative | 2 | 1.69 | 1.77 | 0.08 | 2.07E-16 |
| Tb927.11.16730 | Dihydrolipoyl dehydrogenase | 1 | 1.81 | 1.89 | 0.08 | 6.75E-18 |
| Tb927.10.11190 | tRNA-splicing ligase RtcB, putative | 1 | 1.89 | 1.82 | -0.07 | 4.44E-26 |
| Tb11.v5.0173 | Hypothetical protein, conserved | 3 | 2.01 | 1.9 | -0.11 | 1.32E-28 |
| Tb927.1.3110 | Soluble N-ethylmaleimide sensitive factor (NSF) attachment protein, putative | 2 | 2.03 | 1.74 | -0.29 | 2.09E-22 |
| Tb927.9.10830 | Metal dependent 5’-nucleotidase | 13 | 2.07 | 1.75 | -0.32 | 1.21E-29 |
| Tb927.8.2100 | Vacuolar ATP synthase 16 kDa proteolipid subunit, putative | 1 | 2.43 | 2.07 | -0.36 | 6.84E-18 |
| Tb927.2.2460ii | Ubiquitin-conjugating enzyme E2, putative | 3 | 2.84 | 2.38 | -0.46 | 6.58E-18 |
| Tb927.1.2985 | ER protein Pkr1, putative | 2 | 1.94 | 1.47 | -0.47 | 4.87E-24 |
| Tb927.8.7120 | Squalene synthase, putative | 3 | -1.07 | 1.65 | 2.72 | 2.32E-08 |
| Tb927.10.8050 | TFIIF-stimulated CTD phosphatase, putative | 1 | -1.13 | 1.55 | 2.68 | 9.61E-08 |
| Tb927.9.10280 | Zinc finger CCCH domain-containing protein 48 | 1 | -1.01 | 1.56 | 2.57 | 1.90E-06 |
| Tb927.11.9410 | Hypothetical protein | 1 | 1.6 | 4.16 | 2.56 | 2.36E-17 |
| Tb927.11.4440 | Hypothetical protein | 1 | 1.05 | 2.11 | 1.06 | 8.32E-17 |
| Tb927.2.5980 | Chaperone protein clpb1, putative | 2 | 2.06 | 2.76 | 0.7 | 1.98E-17 |
| Tb927.8.5120 | Cytochrome c | 3 | -5.3 | -4.62 | 0.68 | 1.51E-34 |
| Tb11.V5.0357 | Homocysteine S-methyltransferase, putative | 3 | 1.09 | 1.76 | 0.67 | 7.40E-18 |
| Tb927.11.8470 | Zinc finger protein family member, putative | 1 | 1.29 | 1.83 | 0.54 | 7.51E-05 |
| Tb927.11.20730 | Glycerophosphoryl diester phosphodiesterase, putative | 1 | 1.36 | 1.87 | 0.51 | 7.19E-17 |
| Tb11.V5.0598 | GIY-YIG catalytic domain containing protein, putative | 2 | 1.7 | 2.05 | 0.35 | 3.33E-26 |
| Tb927.3.4170 | CRK9-associated protein | 2 | 1.8 | 2.13 | 0.33 | 4.30E-21 |
| Tb927.11.6640 | Cytochrome b5, putative | 3 | 1.24 | 1.37 | 0.13 | 0.0302 |
| Tb927.6.5010 | Hypothetical protein, conserved | 1 | 1.95 | 2.08 | 0.13 | 6.64E-28 |
| Tb927.8.7820 | ‘Cold-shock’ DNA-binding domain containing protein, putative | 1 | 2.18 | 2.31 | 0.13 | 1.92E-21 |
| Tb927.10.14130 | SRP19 protein, putative | 4 | 1.69 | 1.77 | 0.08 | 2.07E-16 |
| Tb927.3.2200 | TPR repeat, putative | 8 | 1.58 | 1.66 | 0.08 | 7.27E-20 |
| Tb927.4.890 | Small nuclear ribonucleoprotein Sm D3 | 3 | 1.72 | 1.76 | 0.04 | 5.33E-15 |
| Tb927.7.7380 | U6 snRNA-associated Sm-like protein LSm3 | 3 | 1.96 | 2 | 0.04 | 2.51E-24 |
| Tb927.10.5610 | 40S ribosomal protein S9, putative | 1 | -2.06 | -2.04 | 0.02 | 1.84E-15 |
| Tb927.10.3500 | Splicing factor u2af 65 kDa subunit | 4 | 2.09 | 2.1 | 0.01 | 7.08E-30 |
| Tb927.11.11720 | FG-GAP repeat protein, putative | 5 | 1.87 | 1.86 | -0.01 | 1.25E-23 |
| Tb927.10.6380 | Ring finger containing protein | 6 | 1.83 | 1.81 | -0.02 | 8.22E-17 |
| Tb927.3.3470 | Cytochrome b5, putative | 4 | 1.91 | 1.84 | -0.07 | 2.61E-19 |
| Tb927.11.6500 | 40S ribosomal protein S21, putative | 1 | -1.74 | -1.85 | -0.11 | 1.35E-16 |
| Tb927.3.2400 | Palmitoyl acyltransferase 10, putative | 3 | 2.34 | 2.22 | -0.12 | 2.70E-25 |
| Tb927.11.740 | Eukaryotic translation initiation factor 5A | 1 | -1.59 | -1.95 | -0.36 | 9.17E-17 |
| Tb927.10.6060 | Universal minicircle sequence binding protein 2 | 1 | -1.5 | -1.89 | -0.39 | 3.73E-10 |
| Tb927.9.8100 | Nascent polypeptide associated complex subunit, putative | 4 | -1.71 | -2.1 | -0.39 | 5.61E-24 |
| Tb927.10.6070 | Universal minicircle sequence binding protein 1 | 1 | -2.32 | -2.76 | -0.44 | 7.22E-24 |
| Tb927.10.5770 | Valosin-containing protein | 6 | -1.59 | -2.05 | -0.46 | 1.34E-16 |
| Tb927.2.2460ii | Ubiquitin-conjugating enzyme E2, putative | 1 | 2.84 | 2.38 | -0.46 | 6.58E-18 |
| Tb927.11.16130 | Nucleoside diphosphate kinase | 1 | -1.26 | -2.1 | -0.84 | 1.12E-23 |
and ii found at both 6h and 20h.
Figure 10Potential pathway to an effective vaccine for T. evansi in livestock. An outline for developing a genetically manipulated and irradiated but metabolically active vaccine against Trypanosomosis in livestock species. Green signifies areas well studied, green/yellow areas are those that have been attempted, yellow are yet to be studied. White boxes are areas that are continuously under study that produce new information for vaccine development. All genes identified across doses were analysed in a matrix that considers the changes in the level of transcription at 100Gy compared to both 140Gy and 200Gy irradiation of T. evansi and functional analysis using gene ontology enrichment to identify pathways that are affected by low dose irradiation. Further analysis to look at immune functions of genes identified using gene deletion methods e.g., gene knock-out, RNAi or CRISPR/CAS9. Gene insertion of immune modulation ligands would further enhance immunogenicity of the whole parasite inoculum before testing in the mammalian host.